Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I).

Area of Science:

• Cardiology
• Pulmonology
• Pharmacology

Background:

• Amiodarone is a key treatment for cardiac arrhythmias.
• A significant percentage of patients (5-10%) develop amiodarone pulmonary toxicity (APT).
• APT can lead to irreversible pulmonary function loss.

Purpose of the Study:

• To emphasize the importance of early APT recognition.
• To guide clinicians in diagnosing and managing amiodarone-induced lung injury.
• To highlight the need for individualized risk-benefit assessment.

Main Methods:

• Review of clinical data and treatment protocols for amiodarone use.
• Analysis of diagnostic strategies for amiodarone pulmonary toxicity.
• Evaluation of therapeutic interventions and their outcomes.

Main Results:

• Early identification of APT is linked to better patient outcomes.
• Individualized diagnostic and therapeutic approaches are essential.
• Ongoing risk-benefit reevaluation is critical for patient management.

Conclusions:

• Timely diagnosis of amiodarone pulmonary toxicity can prevent permanent lung damage.
• Personalized management strategies are vital for patients on amiodarone.
• Further research is needed to enhance early detection and reversibility of APT.